Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIc (Protocol 55P127): Addition of up to 10 Women to Explore Silver Systemic Absorption as a Continuation Study to: Phase IIb (Protocol 55P140)

NCT05606146 is registered in ClinicalTrials.gov with Ocon Medical Ltd. as lead sponsor.

NCT NCT05606146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05606146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIc (Protocol 55P127): Addition of up to 10 Women to Explore Silver Systemic Absorption as a Continuation Study to: Phase IIb (Protocol 55P140)
Lead sponsor
Ocon Medical Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
February 23, 2023
Completion date
July 31, 2024
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heavy menstrual bleeding